The EuroSciCon's 2015 Innate Immunity Summit, London, UK, 17-19 November 2015 A first line of defense against viral infection is prompted by the innate immune system. Viruses activate both extracellular and intracellular events that lead to a war between the virus and the host. In addition to vaccines which induce adaptive T- and B-cell response in readiness for infection, other therapies that potentiate the host immune response are in development, such as those that induce an increase in restriction factor activity or diminish inflammation through Toll-like receptors' antagonists. Other modulators of immune response, such as thymosin α-1, contribute to the inhibition of HIV-1 and human T lymphotropic virus 1 infection. Understanding the mechanisms by which the innate immune response combats pathogen invasion will enable the generation of novel therapeutic strategies to cure viral infection.
Camprubí Rimblas, M., Peri, F., Mcknight, Á., Matteucci, C., Guillamat Prats, R. (2016). The EuroSciCon's 2015 Innate Immunity Summit. FUTURE VIROLOGY, 11(10), 665-669 [10.2217/fvl-2016-0091].
The EuroSciCon's 2015 Innate Immunity Summit
PERI, FRANCESCOSecondo
;
2016
Abstract
The EuroSciCon's 2015 Innate Immunity Summit, London, UK, 17-19 November 2015 A first line of defense against viral infection is prompted by the innate immune system. Viruses activate both extracellular and intracellular events that lead to a war between the virus and the host. In addition to vaccines which induce adaptive T- and B-cell response in readiness for infection, other therapies that potentiate the host immune response are in development, such as those that induce an increase in restriction factor activity or diminish inflammation through Toll-like receptors' antagonists. Other modulators of immune response, such as thymosin α-1, contribute to the inhibition of HIV-1 and human T lymphotropic virus 1 infection. Understanding the mechanisms by which the innate immune response combats pathogen invasion will enable the generation of novel therapeutic strategies to cure viral infection.File | Dimensione | Formato | |
---|---|---|---|
fvl-2016-0091.pdf
Solo gestori archivio
Dimensione
1.08 MB
Formato
Adobe PDF
|
1.08 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.